Annual Accounts Payable
N/A
31 December 2023
Summary:
TG Therapeutics annual accounts payable is not available.TGTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
N/A
30 September 2024
Summary:
TG Therapeutics quarterly accounts payable is not available.TGTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
TGTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
TG Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $34.66 M(+16.8%) |
| June 2020 | - | $29.67 M(-26.2%) |
| Mar 2019 | - | $40.20 M(+6.0%) |
| Sept 2018 | - | $37.92 M(+7.1%) |
| June 2018 | - | $35.39 M(+8.9%) |
| Mar 2018 | - | $32.51 M(+78.8%) |
| Sept 2017 | - | $18.18 M(-3.9%) |
| Mar 2017 | - | $18.92 M(+23.9%) |
| Dec 2016 | $15.27 M(+63.4%) | $15.27 M(-1.8%) |
| Sept 2016 | - | $15.55 M(+18.9%) |
| June 2016 | - | $13.08 M(+60.7%) |
| Mar 2016 | - | $8.14 M(-12.9%) |
| Dec 2015 | $9.35 M(+134.1%) | $9.35 M(+8.9%) |
| Sept 2015 | - | $8.58 M(+4.0%) |
| June 2015 | - | $8.25 M(-7.1%) |
| Mar 2015 | - | $8.88 M(+122.5%) |
| Dec 2014 | $3.99 M(-16.2%) | $3.99 M(-49.9%) |
| Sept 2014 | - | $7.97 M(+319.5%) |
| June 2014 | - | $1.90 M(+15.9%) |
| Mar 2014 | - | $1.64 M(-65.6%) |
| Dec 2013 | $4.76 M(+326.4%) | $4.76 M(+10.2%) |
| Sept 2013 | - | $4.33 M(+92.4%) |
| June 2013 | - | $2.25 M(+61.9%) |
| Mar 2013 | - | $1.39 M(+24.2%) |
| Dec 2012 | $1.12 M(+67.6%) | $1.12 M(-37.9%) |
| Sept 2012 | - | $1.80 M(+459.3%) |
| June 2012 | - | $321.70 K(-31.2%) |
| Mar 2012 | - | $467.50 K(-29.9%) |
| Dec 2011 | $666.60 K(+198.3%) | $666.60 K(+297.5%) |
| Sept 2011 | - | $167.70 K(-19.2%) |
| June 2011 | - | $207.60 K(+13.3%) |
| Mar 2011 | - | $183.30 K(-18.0%) |
| Dec 2010 | $223.50 K(-23.2%) | $223.50 K(-43.5%) |
| Sept 2010 | - | $395.80 K(+5.9%) |
| June 2010 | - | $373.80 K(+23.5%) |
| Mar 2010 | - | $302.70 K(+3.9%) |
| Dec 2009 | $291.20 K | $291.20 K(+103.5%) |
| Sept 2009 | - | $143.10 K(-17.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $172.90 K(+19.7%) |
| Mar 2009 | - | $144.50 K(-73.4%) |
| Dec 2008 | $542.30 K(-57.6%) | $542.30 K(-23.1%) |
| Sept 2008 | - | $705.30 K(+14.3%) |
| June 2008 | - | $617.30 K(-37.4%) |
| Mar 2008 | - | $986.20 K(-22.9%) |
| Dec 2007 | $1.28 M(-8.2%) | $1.28 M(+50.1%) |
| Sept 2007 | - | $852.50 K(-14.9%) |
| June 2007 | - | $1.00 M(-34.3%) |
| Mar 2007 | - | $1.52 M(+9.4%) |
| Dec 2006 | $1.39 M(-13.9%) | $1.39 M(+28.4%) |
| Sept 2006 | - | $1.09 M(-44.7%) |
| June 2006 | - | $1.96 M(-1.4%) |
| Mar 2006 | - | $1.99 M(+23.1%) |
| Dec 2005 | $1.62 M(+41.4%) | $1.62 M(-5.6%) |
| Sept 2005 | - | $1.71 M(+31.5%) |
| June 2005 | - | $1.30 M(+17.2%) |
| Mar 2005 | - | $1.11 M(-2.8%) |
| Dec 2004 | $1.14 M(+108.5%) | $1.14 M(-17.5%) |
| Sept 2004 | - | $1.39 M(+235.3%) |
| June 2004 | - | $413.50 K(-27.4%) |
| Mar 2004 | - | $569.40 K(+3.8%) |
| Dec 2003 | $548.60 K(+232.7%) | $548.60 K(-27.9%) |
| Sept 2003 | - | $760.50 K(+32.5%) |
| June 2003 | - | $574.00 K(+21.2%) |
| Mar 2003 | - | $473.70 K(+187.3%) |
| Dec 2002 | $164.90 K(-67.6%) | $164.90 K(-67.3%) |
| Sept 2002 | - | $503.90 K(+17.8%) |
| June 2002 | - | $427.70 K(-11.8%) |
| Mar 2002 | - | $484.70 K(-4.7%) |
| Dec 2001 | $508.60 K(-35.3%) | $508.60 K(-32.0%) |
| Sept 2001 | - | $748.40 K(+5.9%) |
| June 2001 | - | $706.90 K(-9.3%) |
| Mar 2001 | - | $779.20 K(-0.8%) |
| Dec 2000 | $785.80 K(+57.2%) | $785.80 K(-26.0%) |
| Sept 2000 | - | $1.06 M(+95.7%) |
| June 2000 | - | $542.50 K(+9.4%) |
| Mar 2000 | - | $495.90 K(-0.8%) |
| Dec 1999 | $500.00 K | $500.00 K |
FAQ
- What is the all time high annual accounts payable for TG Therapeutics?
- What is the all time high quarterly accounts payable for TG Therapeutics?
What is the all time high annual accounts payable for TG Therapeutics?
TG Therapeutics all-time high annual accounts payable is $15.27 M
What is the all time high quarterly accounts payable for TG Therapeutics?
TG Therapeutics all-time high quarterly accounts payable is $40.20 M